Dow Up0.59% Nasdaq Up0.75%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.48 0.02(1.33%) Sep 16, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJul 31, 2014Apr 30, 2014Jan 31, 2014Oct 31, 2013
Total Revenue 5,496   6,474   3,885   7,354  
Cost of Revenue3,583  3,829  2,416  4,195  
Gross Profit 1,913   2,645   1,469   3,159  
Operating Expenses
Research Development10,201  8,813  6,649  6,957  
Selling General and Administrative4,883  4,361  4,563  4,016  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (13,171) (10,529) (9,743) (7,814)
Income from Continuing Operations
Total Other Income/Expenses Net42  281  23  24  
Earnings Before Interest And Taxes(13,129)(10,248)(9,720)(7,790)
Interest Expense -   -  4   -  
Income Before Tax(13,129)(10,248)(9,724)(7,790)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(13,129)(10,248)(9,724)(7,790)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (13,129) (10,248) (9,724) (7,790)
Preferred Stock And Other Adjustments(1,028)(401) -   -  
Net Income Applicable To Common Shares (14,157) (10,649) (9,724) (7,790)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.